Literature DB >> 35012912

[Isolation, identification and safety evaluation of Lactobacillus gasseri strain LGV03 isolated from the vagina of healthy women].

B Su1, L Cao2, J Zheng3, L Zhang3, Z Zhang2, F Qiu2.   

Abstract

OBJECTIVE: To characterize the bacterial strain LGV03 isolated from the reproductive tract of healthy women and evaluate its safety.
METHODS: The bacterial strains were isolated and purified using MRS agar by dilution plating and streak plate method. Gram staining was used to observe the morphology of the isolated strains and identify Gram-negative and -positive strains. The physiological and biochemical properties of the bacteria was assessed using VITEK ANC card. Strain LGV03 was identified by molecular biology and phylogenetic analysis and tested for hemolysis on blood agar plates. E-test method was performed to examine the sensitivity of strain LGV03. The concentration of lactic acid in the culture supernatant of LGV03 was measured using a biochemical analyzer. The safety of LGV03 was evaluated in mice using acute oral toxicity test.
RESULTS: The isolated bacterial strain LGV03 showed good growth under anaerobic conditions at 37 ℃ on MRS medium and formed round, milky white, moist, and opaque colonies with neat margins. The strain LGV03 was positive for Gram staining, rod-shaped with a size range of (0.4-0.5) × (0.9-6.3) μm, and was identified as Lactobacillus gersonii. LGV03 was sensitive to PG, AM, MP, VA, EM and LZ. In MRS medium LGV03 could produce lactic acid, which reached its saturation concentration after 18 h with a final concentration of 1.72 mg/mL. The mice with acute oral exposure to LGV03 showed no significant changes of body weight or organ weight as compared with normal saline-treated mice.
CONCLUSION: The bacterial strain LGV03 isolated from the female reproductive tract was identified as Lactobacillus gersonii with potential probiotic effects and good safety profile.

Entities:  

Keywords:  Lactobacillus gersonii; safety evaluation; separation and identification

Mesh:

Year:  2021        PMID: 35012912      PMCID: PMC8752435          DOI: 10.12122/j.issn.1673-4254.2021.12.08

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  21 in total

1.  Use of the DNA sequence of variable regions of the 16S rRNA gene for rapid and accurate identification of bacteria in the Lactobacillus acidophilus complex.

Authors:  M J Kullen; R B Sanozky-Dawes; D C Crowell; T R Klaenhammer
Journal:  J Appl Microbiol       Date:  2000-09       Impact factor: 3.772

2.  Lactobacillus gasseri causing Fournier's gangrene.

Authors:  Imad M Tleyjeh; Jonathan Routh; Mohammed O Qutub; Garrett Lischer; Kelly V Liang; Larry M Baddour
Journal:  Scand J Infect Dis       Date:  2004

3.  Antibiotic susceptibility of Lactobacillus and Bifidobacterium species from the human gastrointestinal tract.

Authors:  Susana Delgado; Ana Belén Flórez; Baltasar Mayo
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

Review 4.  The role of lactic acid production by probiotic Lactobacillus species in vaginal health.

Authors:  Gilda Tachedjian; Muriel Aldunate; Catronia S Bradshaw; Richard A Cone
Journal:  Res Microbiol       Date:  2017-04-20       Impact factor: 3.992

5.  The PTS transporters of Lactobacillus gasseri ATCC 33323.

Authors:  Alyssa L Francl; Taksawan Thongaram; Michael J Miller
Journal:  BMC Microbiol       Date:  2010-03-12       Impact factor: 3.605

6.  Safety assessment of two probiotic strains, Lactobacillus coryniformis CECT5711 and Lactobacillus gasseri CECT5714.

Authors:  F Lara-Villoslada; S Sierra; R Martín; S Delgado; J M Rodríguez; M Olivares; J Xaus
Journal:  J Appl Microbiol       Date:  2007-07       Impact factor: 3.772

7.  Growth and lactic acid production by vaginal Lactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coli.

Authors:  María Silvina Juárez Tomás; Virginia S Ocaña; Birgitt Wiese; María E Nader-Macías
Journal:  J Med Microbiol       Date:  2003-12       Impact factor: 2.472

Review 8.  The vaginal microbiota: what have we learned after a decade of molecular characterization?

Authors:  Janneke H H M van de Wijgert; Hanneke Borgdorff; Rita Verhelst; Tania Crucitti; Suzanna Francis; Hans Verstraelen; Vicky Jespers
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

9.  Pneumonia and Pleural Empyema due to a Mixed Lactobacillus spp. Infection as a Possible Early Esophageal Carcinoma Signature.

Authors:  Eleftheria Chaini; Nikolaos D Chainis; Anastasios Ioannidis; Maria Magana; Chryssoula Nikolaou; Joseph Papaparaskevas; Melina-Vassiliki Liakata; Panagiotis Katopodis; Leonidas Papastavrou; George P Tegos; Stylianos Chatzipanagiotou
Journal:  Front Med (Lausanne)       Date:  2016-09-28

10.  Exploring potential of vaginal Lactobacillus isolates from South African women for enhancing treatment for bacterial vaginosis.

Authors:  Anna-Ursula Happel; Brian Kullin; Hoyam Gamieldien; Nicole Wentzel; Chambrez Z Zauchenberger; Heather B Jaspan; Smritee Dabee; Shaun L Barnabas; Shameem Z Jaumdally; Janan Dietrich; Glenda Gray; Linda-Gail Bekker; Remy Froissart; Jo-Ann S Passmore
Journal:  PLoS Pathog       Date:  2020-06-04       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.